Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gemcitabine (gemzar) (1 trial)
olaparib (lynparza) (1 trial)
rp-3500 (4 trials)
rp-6306 (4 trials)
talazoparib (talzenna) (1 trial)
trastuzumab (herceptin) (1 trial)
Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (6 total)